ADIL - Adial Pharmaceuticals, Inc.

Insider Record

In the last 12 months only funds and other entities traded ADIL in the open market: 3 purchases worth about $106K.

No insider has bought ADIL shares in the open market in the last two years. The last purchase on record was by Kevin Schuyler on September 29, 2023.

Role	Insider	Shares	Value	30d
10%	Coastlands Capital LP	388.3K	$1.96M	-
Other	Matt Davidson	304.7K	$1.54M	-
CEO	Cary J Claiborne	40.4K	$204.1K	-
COO	Tony Goodman	26.5K	$133.9K	-
CFO	Vinay Shah	17.3K	$87.5K	-

Buys and sells only

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 16, 2026	Coastlands Capital LP62	10% Owner	Buy	3,233	$2.69	$8,690.75	+0.8%	+7.5%	-
Jul 10, 2026	Coastlands Capital LP62	10% Owner	Buy	11,753	$2.78	$32,637.87	+3.1%	+42.8%	-
Jun 29, 2026	Coastlands Capital LP62	10% Owner	Buy	25,000	$2.60	$65,000.00	+7.2%	+56.0%	-
Sep 29, 2023	Kevin Schuyler	Director	Buy	700	$2.74	$1,918.00	New	-36.3%	-63.7%
Dec 30, 2021	James W. Newman Jr.	Director	Buy	25,000	$2.69	$67,300.00	+259.2%	-25.1%	-91.9%
Nov 30, 2021	William B. Stilley III	Chief Executive Officer	Buy	20,600	$2.67	$55,070.62	+2.2%	-25.9%	-90.3%
Nov 26, 2021	James W. Newman Jr.	Director	Buy	10,000	$2.85	$28,500.00	+40.9%	-23.5%	-90.2%
Oct 4, 2021	Bankole A. Johnson	Chief Medical Officer	Sell	200,000	$0.00	-	-57.4%	-26.6%	-90.1%
Apr 6, 2021	Bankole A. Johnson	Chief Medical Officer	Sell	150,000	$2.50	$375,000.00	-21.5%	+13.1%	-26.3%
Aug 20, 2020	Bankole A. Johnson	Chief Medical Officer	Sell	350,000	$1.21	$423,500.00	-99.7%	-	-